Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TAAR1 | Q96RJ0 | 2/20 | 0.50 |
| ▸ | PORCN | Q9H237 | 1/20 | 0.46 |
| ▸ | IMPDH2 | P12268 | 3/20 | 0.46 |
| ▸ | IMPDH1 | P20839 | 1/20 | 0.46 |
| ▸ | MEN1 | O00255 | 1/20 | 0.46 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.46 |
| ▸ | AAK1 | Q2M2I8 | 1/20 | 0.45 |
| ▸ | NPC1 | O15118 | 6/20 | 0.45 |
| ▸ | RAB9A | P51151 | 5/20 | 0.45 |
| ▸ | KDM4E | B2RXH2 | 4/20 | 0.45 |
| ▸ | PKM | P14618 | 2/20 | 0.45 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.45 |
| ▸ | LMNA | P02545 | 1/20 | 0.45 |
| ▸ | NOX1 | Q9Y5S8 | 1/20 | 0.42 |
| ▸ | JAK3 | P52333 | 1/20 | 0.41 |
| ▸ | MAPK1 | P28482 | 2/20 | 0.41 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.41 |
| ▸ | HTT | P42858 | 1/20 | 0.41 |
| ▸ | GSK3B | P49841 | 1/20 | 0.40 |
| ▸ | DYRK1A | Q13627 | 1/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5779523 | 1.00 | TAAR1 (0.50) | TAAR1PORCNIMPDH2IMPDH1MEN1 | |
| SCHEMBL5780111 | 0.85 | NOX1 (0.60) | PORCNIMPDH2IMPDH1MEN1KMT2A | |
| SCHEMBL5780110 | 0.85 | NOX1 (0.60) | PORCNIMPDH2IMPDH1MEN1KMT2A | |
| SCHEMBL5779459 | 0.83 | NPC1 (0.46) | IMPDH2IMPDH1MEN1KMT2AAAK1 | |
| SCHEMBL5779782 | 0.82 | LMNA (0.40) | IMPDH2IMPDH1MEN1KMT2AAAK1 | |
| SCHEMBL5779785 | 0.82 | LMNA (0.40) | IMPDH2IMPDH1MEN1KMT2AAAK1 | |
| SCHEMBL5775270 | 0.82 | NPC1 (0.42) | PORCNIMPDH2IMPDH1MEN1KMT2A | |
| SCHEMBL5777532 | 0.82 | IMPDH2 (0.41) | PORCNIMPDH2IMPDH1MEN1KMT2A | |
| SCHEMBL5775267 | 0.82 | NPC1 (0.42) | PORCNIMPDH2IMPDH1MEN1KMT2A | |
| SCHEMBL5777534 | 0.82 | IMPDH2 (0.41) | PORCNIMPDH2IMPDH1MEN1KMT2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20060276433-A1 | Hydrazone derivative | DAIICHI PHARMACEUTICAL CO., LTD. (JP) | 2006-12-07 | — | — | US | disclosed |
| EP-1612204-A1 | HYDRAZONE DERIVATIVE | DAIICHI PHARMACEUTICAL CO., LTD. (JP) | 2006-01-04 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20060276433-A1 | Hydrazone derivative | APP, PRNP, HTT | TAAR1 793/4885PORCN 3789/4885IMPDH2 4694/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.